1. Home
  2. LQDT vs ANAB Comparison

LQDT vs ANAB Comparison

Compare LQDT & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

N/A

Current Price

$44.60

Market Cap

1.4B

ML Signal

N/A

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

SELL

Current Price

$47.44

Market Cap

1.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LQDT
ANAB
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
LQDT
ANAB
Price
$44.60
$47.44
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$51.00
★ $87.25
AVG Volume (30 Days)
190.4K
★ 447.0K
Earning Date
11-19-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
38.10
★ 91.02
EPS
★ 0.78
N/A
Revenue
★ $476,669,000.00
$234,603,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$69.42
P/E Ratio
$57.29
★ N/A
Revenue Growth
31.20
★ 157.01
52 Week Low
$21.67
$30.27
52 Week High
$45.92
$73.30

Technical Indicators

Market Signals
Indicator
LQDT
ANAB
Relative Strength Index (RSI) 54.75 44.91
Support Level $36.82 $44.38
Resistance Level $45.92 $51.94
Average True Range (ATR) 1.06 2.27
MACD 0.01 0.25
Stochastic Oscillator 51.20 44.55

Price Performance

Historical Comparison
LQDT
ANAB

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: